¼¼°èÀÇ ¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ½ÃÀå
Energy-based Non-Invasive Medical Aesthetics
»óǰÄÚµå : 1757554
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 280 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,009,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,027,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ½ÃÀåÀº 2030³â±îÁö 59¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 33¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 10.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 59¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÇǺΠȸÃá ¾ÖÇø®ÄÉÀ̼ÇÀº CAGR 10.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 24¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áú ȸÃá ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 8.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8¾ï 9,440¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 14.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ½ÃÀåÀº 2024³â¿¡ 8¾ï 9,440¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 12¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 14.1%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 7.4%¿Í 9.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 8.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿¡³ÊÁö ¾ç½ÄÀÇ Çõ½ÅÀº ¹Ì¿ë Ä¡·áÀÇ »óȲÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ºÐ¾ß¸¦ ÀçÁ¤ÀÇÇÏ´Â Áß½ÉÀûÀÎ ÈûÀ¸·Î ±â¼ú À¶ÇÕÀÌ ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ·¹ÀÌÀú, °íÁÖÆÄ(RF), ÃÊÀ½ÆÄ, ¸¶ÀÌÅ©·ÎÆÄ, °­·ÂÇÑ ÆÞ½º±¤(IPL) ±â¼úÀ» ÇÏÀ̺긮µå Àåºñ¿¡ ÅëÇÕÇÏ¿© Á¤È®¼º, Á¦¾î ¹× Ä¡·áÀÇ ¸ÂÃãÈ­¸¦ ȹ±âÀûÀ¸·Î °³¼±Çß½À´Ï´Ù. ¸ÖƼ ¸ðµå Ç÷§ÆûÀº ÇǺΠź·Â, Áö¹æ °¨¼Ò, ¼¿·ê¶óÀÌÆ® Ä¡·á, ¾ó±¼ ȸÃá¿¡ ½Ã³ÊÁö È¿°ú¸¦ Á¦°øÇϱâ À§ÇØ ´ÜÀÏ ¸ðµå Àåºñ¸¦ ´ëüÇϰí ÀÖ½À´Ï´Ù. ÀýÁ¦¿Í ºñÀýÁ¦¸¦ °áÇÕÇÑ ÇÁ¶ô¼Å³Î ·¹ÀÌÀú ½Ã½ºÅÛÀº ´Ù¿îŸÀÓ ¾øÀÌ º¹ÀâÇÑ ÁøÇÇÃþÀ» Ä¡·áÇÒ ¼ö ÀÖÀ¸¹Ç·Î ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ´õ ³ôÀº ħÅõ ±íÀÌ¿Í ÃÊÁ¡ Á¤È®µµ¸¦ Á¦°øÇÏ´Â Â÷¼¼´ë ÃÊÀ½ÆÄ Ç÷§ÆûÀÇ °³¹ß·Î ÀÓ»óÀÇ´Â ÀÌÀü¿¡´Â ¼ö¼úÀû ¹æ¹ýÀ¸·Î¸¸ °¡´ÉÇß´ø ¸®ÇÁÆÃ°ú À±°ûÀ» À§ÇÑ ÇÇÇÏÁ¶Á÷À» Ÿ°ÙÆÃÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¼ÒÇüÈ­¿Í AI ±â¹Ý Á¦¾î ½Ã½ºÅÛ ¶ÇÇÑ ¿¡³ÊÁö °ø±Þ¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ÇǺΠÀÓÇÇ´ø½º¿Í ¿­ ÀÓ°è°ª¿¡ ¹ÝÀÀÇÏ´Â ÀûÀÀÇü Çǵå¹é ¸ÞÄ¿´ÏÁòÀº È­»óÀ̳ª ºÒ±ÕÀÏÇÑ °á°ú¿Í °°Àº À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ RF ±â¼ú°ú ÅëÇÕµÈ ³Ãµ¿ Áö¹æ ºÐÇØ Àåºñ´Â Àú¿Â Ä¡·á¸¦ ÅëÇÑ ¼¼Æ÷ »ç¸ê°ú RF °¡¿­À» ÅëÇÑ Äݶó°Õ ÀÚ±ØÀÇ ÀÌÁß ÀÛ¿ëÀ» Á¦°øÇÕ´Ï´Ù. °æÀï ±â¼ú ȯ°æÀº ÇöÀç µ¶ÀÚÀûÀÎ ¾Ë°í¸®Áò°ú ƯÇã·Î º¸È£µÇ´Â ¿¡³ÊÁö º¯Á¶ ½Ã½ºÅÛÀ» º¸À¯ÇÑ ¾÷ü¿¡°Ô À¯¸®Çϸç, ´Ù¾çÇÑ »çÁø À¯Çü°ú ÇǺΠ»óÅ¿¡ °ÉÃÄ ¸ÂÃãÇü Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¿©µå¸§ ÈäÅÍ, Ç÷°ü º´º¯, ÁÖ»çºñ¿Í °°Àº °í±Þ ÀûÀÀÁõÀ» Æ÷ÇÔÇÏ¿© ½ÃÀåÀ» È®´ëÇϰí ÀÓ»ó ÀÌ¿ë »ç·Ê¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

ºñħ½ÀÀû ¹Ì¿ë±â±â ¼ö¿ä ±ÞÁõ¼¼¸¦ ÁÖµµÇÏ´Â ÃÖÁ¾»ç¿ëÀÚ ºÎ¹®Àº?

ÀÇ·á¿ë ½ºÆÄ, ÇǺΰú, ¼ºÇü¿Ü°ú°¡ ¿©ÀüÈ÷ Àåºñ µµÀÔÀÇ ÃÖÀü¼±¿¡ ÀÖÁö¸¸, °¡Á¤¿ë ¹Ì¿ë ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ Àüü Á¦°ø ¸ðµ¨¿¡ ÆÄ±Þ È¿°ú¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. Àǻ簡 Á¶Á¦ÇÏ´Â ¿¡³ÊÁö ±â¹Ý ÇÚµåÇïµå ±â±â´Â ÇöÀç ÀÓ»óÀû Áöħ¿¡ µû¶ó °³ÀÎ »ç¿ëÀ» À§ÇØ ´õ ³·Àº ¿¡³ÊÁö ÀÓ°è°ªÀ¸·Î Ãâ½ÃµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â »ç½Ç»ó Ŭ¸®´Ð ¼öÁØÀÇ Ä¡·á¸¦ °¡Á¤À¸·Î °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ÀÇ µµ½Ã Áö¿ª³» À£´Ï½º üÀÎ ¹× Á¾ÇÕ ºäƼ Ŭ¸®´Ð ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ´Â °Íµµ Áö¿ªÀû ´Ù¾çÈ­¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀº µÎ ÀÚ¸´¼ö ½Ã¼ú ¼ºÀå·üÀ» ±â·ÏÇϰí ÀÖÀ¸¸ç, ºÏ¹Ì¿Í À¯·´À» ´É°¡ÇÏ´Â ½Ã¼ú·® È®´ë¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

³²¼ºÀº À±°û ¼ºÇü, Á¦¸ð, ÇǺΠŸÀÌÆ®´×¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â Áß¿äÇÑ Àα¸ Áý´ÜÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó µ¿Çâ¿¡ µû¸£¸é ƯÁ¤ Áö¿ª, ƯÈ÷ ´ëµµ½Ã ½ÃÀå¿¡¼­´Â ³²¼º °í°´ÀÌ Ä¡·á °Ç¼öÀÇ ÃÖ´ë 25%¸¦ Â÷ÁöÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¼ºº°¿¡ ƯȭµÈ ÇÁ·ÎÅäÄÝ, ´õ ºü¸¥ Ä¡·á ÁÖ±â, µÎ²¨¿î ÇÇºÎ¿Í °ÅÄ£ ¸ð³¶¿¡ ÀûÇÕÇÑ ´õ ±íÀº ħÅõ ¿¡³ÊÁö ¸ðµå¸¦ Æ÷ÇÔÇÑ Àåºñ ¼³°è¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÇÑÆí, ½ÅÈï °æÁ¦±¹¿¡¼­´Â °í·ÉÈ­°¡ ÁøÇàµÇ¸é¼­ ´Ù¿îŸÀÓÀÌ ÀûÀº À¯Áöº¸¼ö Ä¡·á¸¦ ¿øÇÏ´Â »ç¶÷µéÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀüÅëÀûÀÎ ¼ö¼úÀû ´ë¾È¿¡ ºñÇØ ºñħ½ÀÀû ¼Ö·ç¼ÇÀÌ Á¡Á¡ ´õ ¸Å·ÂÀûÀ¸·Î ´Ù°¡¿À°í ÀÖ½À´Ï´Ù. ¹Ì¿ë Ä¡·á¿Í ³ëÈ­ ¿¹¹æ Àü·«ÀÇ °áÇÕÀº ¹Ýº¹ÀûÀÎ ½Ã¼úÀÌ ÇÊ¿äÇÑ º¹ÇÕ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ âÃâÇϰí, Àåºñ´ç ÀÌ¿ë·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

±ÔÁ¦ ¿ªÇÐ ¹× ÀÓ»ó È¿°ú ±âÁØÀÌ ½ÃÀå È®´ë¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½ÃÀåÀÌ ¼º¼÷ÇØÁü¿¡ µû¶ó ±ÔÁ¦ÀÇ ¾ö°ÝÇÔ°ú ÀÓ»ó °ËÁõÀº Á¦Ç° °³¹ß ¹× »ó¾÷È­ Àü·«ÀÇ Çü¼º¿¡ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ FDA, CE ¸¶Å© ´ç±¹ ¹× ¾Æ½Ã¾Æ ±ÔÁ¦±â°üÀº ±â±âÀÇ È¿´É È¿°ú¿¡ ´ëÇÑ ±ÔÁ¦¸¦ °­È­Çϰí Á¾´ÜÀû ÀÓ»ó½ÃÇè µ¥ÀÌÅÍ, º´¸® Á¶Á÷ÇÐÀû Áõ°Å, »ç¿ëÀÚ ¾ÈÀü º¥Ä¡¸¶Å·À» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ¿¡³ÊÁö ±â¹Ý ¿¡½ºÅׯ½ ±â¾÷Àº ÀÌ·¯ÇÑ ¿ä±¸ »çÇ×À» ÃæÁ·ÇÏ°í ¸¶ÄÉÆÃ ÁÖÀåÀ» Áö¿øÇϱâ À§ÇØ ´Ù±â°ü ÀÓ»ó½ÃÇè¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. Áö¹æ °¨¼Ò, ÇǺΠÀçÇ¥¸é, ÁøÇÇ ¸®¸ðµ¨¸µÀ» Ç¥¹æÇÏ´Â ±â±âµéÀº ÇöÀç À§¾àÀ̳ª ±âÁ¸ ±â¼ú¿¡ ºñÇØ Åë°èÀûÀ¸·Î À¯ÀǹÌÇÑ °³¼± È¿°ú¸¦ ÀÔÁõÇÒ ¼ö ÀÖ´Â Áõ°Å¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÓ»óÀû È¿°ú°¡ ÀÔÁõµÈ ¾÷üµéÀº ½ÃÀå¿¡¼­ °¡°Ý ÇÁ¸®¹Ì¾öÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÓ»ó°ú ¹Ì¿ëÀÇ ÇÏÀ̺긮µå ¸ðµ¨, ƯÈ÷ ÀÇ·áÇǺΰú¿Í °æ°è¿¡ ÀÖ´Â ½Ã¼ú¿¡ ´ëÇÑ »óȯÀÌ »õ·Î¿î °ü½É»ç·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ¿©µå¸§, Ç÷°ü ÀÌ»ó, ¼ö¼ú ÈÄ ÈäÅÍ Ä¡·á¿¡ À¯¿ë¼ºÀ» ÀÔÁõÇÑ ±â±â´Â Ä¡·á¿ë ¿ëµµ°úÀÇ °øµ¿ ÆÇ¸Å°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÇÏÀ̺긮µå ¼öÀÔ¿øÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ RF ±â¹Ý ¸¶ÀÌÅ©·Î´Ïµé ¹× ±¹¼Ò¿ë ¼¼·³°ú °°ÀÌ ´õ ³ªÀº Èí¼ö¿Í °á°ú¸¦ ÃÊ·¡ÇÏ´Â º´¿ë ¿ä¹ýÀ» ÃËÁøÇϱâ À§ÇØ ±â±â Á¦Á¶¾÷ü¿Í Á¦¾à ºê·£µå¿ÍÀÇ Á¦ÈÞ°¡ ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¸Á¶ Àü·«À» µµÀÔÇÏ´Â ±â±â Á¦Á¶¾÷ü´Â ±ÔÁ¦ ¹× »ó¾÷Àû ÀÌÁ¡À» ¾ò°í ÀÖ½À´Ï´Ù. ÇÑÆí, ÀÇ·á Ã¥ÀÓ°ú ¾ÈÀü¿¡ ´ëÇÑ °¡À̵å¶óÀεµ ¹ßÀüÇϰí ÀÖÀ¸¸ç, Àü¹® ÇÐȸ´Â ½Ã¼ú À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇÑ ÀÎÁõ ÇÁ·Î±×·¥°ú Ç¥ÁØÈ­µÈ ±³À° ÇÁ·ÎÅäÄÝÀ» ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù.

°¢ Áö¿ªº°·Î ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¼ºÀå µ¿·ÂÀº ¹«¾ùÀΰ¡?

¿¡³ÊÁö ±â¹Ý ºñħ½ÀÀû ¸ÞµðÄà ¿¡½ºÅׯ½ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Çõ½Å, ¼ÒºñÀÚ ÇൿÀÇ º¯È­, ÀÓ»ó ÀÌ¿ë »ç·ÊÀÇ È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °¡Àå °­·ÂÇÑ ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¹Ì¿ë Ä¡·áÀÇ °¡°Ý ÀÎÇÏ¿Í Á¢±Ù¼º Çâ»óÀ̸ç, ÀÌ´Â Àåºñ ÀÓ´ë, »ç¿ë·®º° ¿ä±ÝÁ¦, ¹øµé Ä¡·á ±¸µ¶°ú °°Àº ±ÝÀ¶ ¸ðµ¨¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº ½ÅÈï ½ÃÀåÀÇ ¼Ò±Ô¸ð Ŭ¸®´Ð°ú °³ÀÎ °³¾÷Àǵ鿡°Ôµµ °í±Þ Àåºñ¿¡ ´ëÇÑ Á¢±ÙÀ» ¹ÎÁÖÈ­½Ã۰í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ¼ÒÇü ¿¡³ÊÁö ±â¹Ý ½Ã½ºÅÛÀÇ È®À强À» ÅëÇØ Tier 2 ¹× Tier 3 µµ½ÃÀÇ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ´ë±Ô¸ð ÀÎÇÁ¶ó ÅõÀÚ ¾øÀ̵µ ±¤¹üÀ§ÇÑ ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸¶Âù°¡Áö·Î Áß¿äÇÑ °ÍÀº ¼Ò¼È¹Ìµð¾î¿Í µðÁöÅÐ ¹ÌÇÐÀÌ ¼ÒºñÀÚÀÇ Àνİú ¿­¸ÁÇÏ´Â ¼ö¿ä¸¦ ÀÚ±ØÇÏ´Â µ¥ ¹ÌÄ¡´Â ¿µÇâÀÔ´Ï´Ù. ÀνºÅ¸±×·¥À̳ª ƽÅå°ú °°Àº Ç÷§ÆûÀº ¹Ì¿ë ½Ã¼úÀÇ ºñ°ø½ÄÀûÀÎ ¸¶ÄÉÆÃ ºÎ¹®À¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, ÀþÀº ÃþÀÌ ¾ó±¼ À±°û, »ö¼ÒÄ§Âø ±³Á¤, ÁÖ¸§ °ü¸®¿Í °°Àº ºñħ½ÀÀû ¼Ö·ç¼ÇÀ» ¸ð»öÇϵµ·Ï ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¹Ð·¹´Ï¾ó ¼¼´ë¿Í Z¼¼´ëÀÇ ¹Ì¿ë Ä¡·áÀÇ ÀÏ»óÈ­´Â ÃÖÁ¾»ç¿ëÀÚÀÇ ¿¬·É ½ºÆåÆ®·³À» ³ÐÈ÷´Â µ¿½Ã¿¡ ¼¼¼ÇÀÇ ºóµµ¿Í ȯÀÚ ´ç Æò»ý °¡Ä¡¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. °èÀýº° ÇÁ·Î¸ð¼Ç, ÀÎÇ÷ç¾ð¼­¿ÍÀÇ Çù¾÷, µðÁöÅзΠÅëÇÕµÈ ¿¹¾à ½Ã½ºÅÛ µîÀ» ÅëÇØ ¹Ì¿ë ½Ã¼úÀº ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ ÀϺΰ¡ µÇ¾ú½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¼ºÀå ¿äÀÎÀº ¿¡³ÊÁö ±â¹Ý Ç÷§ÆûÀÇ ÀÓ»óÀû ´Ù¾ç¼º¿¡ ÀÖ½À´Ï´Ù. ÀýÁ¦ ¹× ºñÀýÁ¦ ¿¡³ÊÁö Á¶»ç¸¦ °áÇÕÇÑ Àåºñ´Â ÀÌÀü ¼¼´ëÀÇ ÇѰ迴´ø ¿°Áõ ÈÄ »ö¼ÒÄ§ÂøÀÇ À§Çè ¾øÀÌ ´õ ³ÐÀº ¹üÀ§ÀÇ ÇÇÃ÷ÆÐÆ®¸¯ ÇǺΠÀ¯Çü¿¡ ´ëÀÀÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±× °á°ú, ÀÎÁ¾ÀûÀ¸·Î ´Ù¾çÇÑ ½ÃÀåÀÇ ½Ã¼úÀÚµéÀº ´õ ¸¹Àº °í°´Ãþ¿¡ ´ëÇÑ ¼­ºñ½º Á¦°øÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, ·Îº¿ º¸Á¶ ¿¡³ÊÁö Á¶»ç ¾Ï°ú ½Ç½Ã°£ À̹ÌÁö ÅëÇÕ°ú °°Àº º¸Á¶ ±â¼úÀÇ µîÀåÀº Á¤È®¼º°ú ÀçÇö¼ºÀ» ³ô¿© ȯÀÚµéÀÇ ½Å·Ú¿Í ½Ã¼úÀÇ ´ëÁßÈ­¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÇÕÀûÀÎ ÈûÀ¸·Î ÇâÈÄ 5³â°£ ¼¼°è ½ÃÀåÀº µÎ ÀÚ¸´¼ö ¼ºÀåÀ» Áö¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

¿ëµµ(ÇǺΠȸÃá ¿ëµµ, Áú ȸÃá ¿ëµµ, Á¦¸ð ¿ëµµ, ÇÏÁö Á¤¸Æ Ä¡·á ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(¸Þµå½ºÆÄ ÃÖÁ¾ ¿ëµµ, º´¿ø¡¤¼ö¼ú ¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, HCP ¼ÒÀ¯ Ŭ¸®´Ð ÃÖÁ¾ ¿ëµµ, ÀüÅëÀû ½ºÆÄ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÇÕ°è 34»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Energy-based Non-Invasive Medical Aesthetics Market to Reach US$5.9 Billion by 2030

The global market for Energy-based Non-Invasive Medical Aesthetics estimated at US$3.3 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2024-2030. Skin Rejuvenation Application, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Vaginal Rejuvenation Application segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$894.4 Million While China is Forecast to Grow at 14.1% CAGR

The Energy-based Non-Invasive Medical Aesthetics market in the U.S. is estimated at US$894.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Energy-Based Non-Invasive Medical Aesthetics Market - Key Trends & Drivers Summarized

How Are Innovations in Energy Modalities Reshaping the Aesthetic Treatment Landscape?

Technological convergence has emerged as a central force in redefining the field of energy-based non-invasive aesthetic medicine. The integration of laser, radiofrequency (RF), ultrasound, microwave, and intense pulsed light (IPL) technologies into hybrid devices has dramatically improved precision, control, and treatment customization. Multi-modal platforms are replacing single-mode devices to offer synergistic effects in skin tightening, fat reduction, cellulite treatment, and facial rejuvenation. Fractional laser systems that combine ablative and non-ablative capabilities are being widely adopted for their efficacy in treating complex dermal layers without downtime. The development of next-generation ultrasound platforms offering higher penetration depth and focal accuracy is allowing clinicians to target subcutaneous tissues for lifting and contouring purposes-previously achievable only through surgical methods.

Miniaturization and AI-driven control systems are also revolutionizing energy delivery. Adaptive feedback mechanisms that respond to real-time skin impedance and thermal thresholds are minimizing risks such as burns and uneven outcomes. Furthermore, cryolipolysis units integrated with RF technology are offering dual action-cellular apoptosis through cold treatment followed by collagen stimulation through RF heating. The competitive technology landscape now favors vendors with proprietary algorithms and patent-protected energy modulation systems, which can deliver customized therapy across different phototypes and skin conditions. This shift is expanding the market to include advanced indications like acne scarring, vascular lesions, and rosacea, thereby broadening clinical use cases.

Which End-User Segments Are Driving the Demand Surge in Non-Invasive Aesthetic Devices?

Medical spas, dermatology clinics, and aesthetic surgery centers remain at the forefront of equipment adoption, but the growing consumer preference for at-home aesthetic solutions is causing a ripple effect across the delivery model. Physician-dispensed, energy-based handheld devices are now being launched with lower energy thresholds for personal use under clinical guidance, effectively bringing clinic-quality treatments into consumer homes. A marked increase in demand from wellness chains and integrated aesthetic clinics in urban centers across Asia-Pacific, Latin America, and the Middle East is also contributing to geographic diversification. These regions are registering double-digit procedural growth rates, outpacing North America and Europe in procedural volume expansion.

Men are emerging as a critical demographic segment, driving demand for body contouring, hair removal, and skin tightening solutions. According to clinical practice trends, male clientele is now accounting for up to 25% of treatment volumes in certain geographies, especially in metropolitan markets. This shift is influencing the design of devices to include gender-specific protocols, faster treatment cycles, and deeper penetration energy modes suitable for thicker skin and coarser hair follicles. Meanwhile, aging populations in developed economies are seeking maintenance treatments with lower downtime, making non-invasive solutions increasingly attractive compared to traditional surgical options. The convergence of aesthetic treatments with preventive aging strategies is creating recurring demand for combination therapies that require repeat sessions, driving higher utilization per device.

Why Are Regulatory Dynamics and Clinical Efficacy Standards Becoming Crucial to Market Expansion?

As the market matures, regulatory rigor and clinical validation are playing an outsized role in shaping product development and commercialization strategies. The U.S. FDA, CE Mark authorities, and Asian regulatory bodies are tightening controls on device efficacy claims, demanding longitudinal clinical trial data, histopathological evidence, and user safety benchmarks. Energy-based aesthetic companies are investing heavily in multicentric clinical trials to meet these requirements and support marketing claims. Devices with claims for fat reduction, skin resurfacing, and dermal remodeling now require evidence showing statistically significant improvement over placebo and legacy technologies. Consequently, vendors with proven clinical efficacy are commanding a pricing premium in the market.

Moreover, reimbursement is becoming a topic of renewed interest in hybrid clinical-aesthetic models, particularly in procedures that border medical dermatology. Devices that demonstrate utility in treating acne vulgaris, vascular anomalies, or post-surgical scarring are increasingly being co-marketed with therapeutic applications, creating hybrid revenue streams. Additionally, partnerships between device companies and pharmaceutical brands are evolving to promote combination therapies-such as RF-based microneedling with topical serums-which provide better absorption and outcomes. Device manufacturers that incorporate such adjunctive strategies are gaining regulatory and commercial advantages. Meanwhile, medical liability and safety guidelines are also evolving, prompting professional societies to outline certification programs and standardized training protocols to minimize procedural risks.

What Are the Key Growth Catalysts Powering Market Momentum Across Regions?

The growth in the energy-based non-invasive medical aesthetics market is driven by several factors that span technological innovation, shifting consumer behavior, and expanding clinical use cases. One of the strongest growth drivers is the rising affordability and accessibility of aesthetic treatments, aided by financial models such as device leasing, pay-per-use plans, and bundled treatment subscriptions. These approaches are democratizing access to high-end devices for small clinics and even solo practitioners in emerging markets. The scalability of portable and compact energy-based systems is further enabling providers in tier-2 and tier-3 cities to offer a wide range of services without significant infrastructure investments.

Equally important is the impact of social media and digital aesthetics in fueling consumer awareness and aspirational demand. Platforms such as Instagram and TikTok are acting as unofficial marketing arms for aesthetic procedures, influencing younger populations to explore non-invasive solutions for facial contouring, pigmentation correction, and wrinkle management. The normalization of aesthetic treatments among millennials and Gen Z is expanding the age spectrum of end-users, while increasing session frequency and lifetime value per patient. Seasonal promotions, influencer collaborations, and digitally integrated appointment booking systems are making aesthetic procedures a part of lifestyle routines.

Another pivotal growth factor lies in the clinical versatility of energy-based platforms. Devices that combine ablative and non-ablative energy delivery can now cater to a broader range of Fitzpatrick skin types without risking post-inflammatory hyperpigmentation-a limitation in earlier generations. As a result, practitioners in ethnically diverse markets are expanding service offerings to a larger client base. Simultaneously, the rise of adjunct technologies such as robotic-assisted energy delivery arms and real-time imaging integration are enhancing precision and reproducibility, boosting patient confidence and procedural uptake. These combined forces are expected to drive sustained double-digit growth in the global market over the next five years.

SCOPE OF STUDY:

The report analyzes the Energy-based Non-Invasive Medical Aesthetics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Skin Rejuvenation Application, Vaginal Rejuvenation Application, Hair Removal Application, Leg Vein Treatment Application, Other Applications); End-Use (Medspa End-Use, Hospitals & Surgery Center End-Use, HCP Owned Clinic End-Use, Traditional Spa End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â